Evitria
Pre-clinicalSpecializing in recombinant antibody expression in CHO cells for cutting-edge therapies. Begin your project within 24 hours with evitria's speedy and tailored services.
Founded
2006
Focus
AntibodiesBiologics
About
Specializing in recombinant antibody expression in CHO cells for cutting-edge therapies. Begin your project within 24 hours with evitria's speedy and tailored services.
Funding History
2Total raised: $13M
Series A$10MRedalpineJun 15, 2021
Seed$3MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2006
LocationZurich, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile